M. Kinder
Immunology · 2011–2013
A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Immunology — 27 citations into it
Whom M. Kinder trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from M. Kinder's perspective
Ordered by how strongly the researchers M. Kinder trusts endorse each paper. Same corpus, a different order for every researcher.
- The origin and development of nonlymphoid tissue CD103+ DCs (Journal of Experimental Medicine)
- Type I interferons in host defense. (Immunity)
- Engineered antibody Fc variants with enhanced effector function.
- Cutting Edge: Type I IFNs Provide a Third Signal to CD8 T Cells to Stimulate Clonal Expansion and Differentiation1 (Journal of Immunology)
- FcRn: the neonatal Fc receptor comes of age
- Tolerogenic dendritic cells. (Annual Review of Immunology)
- Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8α+ conventional dendritic cells (Journal of Experimental Medicine)
- Natural innate and adaptive immunity to cancer. (Annual Review of Immunology)
- Taking dendritic cells into medicine (Nature)
- Tumor imaging by means of proteolytic activation of cell-penetrating peptides. (Proceedings of the National Academy of Sciences of the United States of America)
Their papers
- Engineered Protease-resistant Antibodies with Selectable Cell-killing Functions* (2013) — 41 citations
- Type I interferon is selectively required by dendritic cells for immune rejection of tumors (2011) — 1,089 citations